Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Takes Exclusive License to GenWay Biotech s Microbeads

NEW YORK, March 31 (GenomeWeb News) - Beckman Coulter has obtained an exclusive license to microbead technology made by San Diego-based GenWay Biotech, the companies announced today.


Under the terms of the agreement, GenWay will provide Beckman with access to its IgY microbead technology, which can be used to selectively partition the most abundant proteins from human serum or plasma in sample preparation for proteomics applications.


Financial details of the deal were not disclosed.